INS and Hypoglycemia: During the maintenance period, it is important that insulin dose adjustments are continued, albeit less intensively than during the titration period, to ensure that patients maintain glycaemic targets and avoid hypoglycaemia; as such, this period may represent the ongoing clinical reality for patients using BIs.